BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 679196)

  • 1. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL; Cruze PG
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of carminomycin on leukemic cell proliferation and some problems of its use in the combined therapy of leukemias].
    Egorov LV; Khanykova OK; Kuznetsova TV; Rudneva NA; Kozinets GI
    Antibiotiki; 1978 Sep; 23(9):833-6. PubMed ID: 697341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor activity of the components of a carminomycin complex].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
    Khanykova OK; Vinogorova GF
    Antibiotiki; 1977 Sep; 22(9):846-52. PubMed ID: 911158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carminomycin in combination with some cytostatics. 1. Efficacy in leukemia L1210].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1983; 53(1):45-52. PubMed ID: 6860085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antileukemic activity of carminomycin complexes with a high-polymer DNA].
    Vaĭnberg IuP; Egorov LV; Kuznetsova TV; Rudneva NA; Khanykova OK
    Antibiotiki; 1980 Jun; 25(6):454-8. PubMed ID: 7396445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of carminomycin on the kinetics of cell proliferation and some problems of its combined use with other cytostatic agents].
    Egorov LV; Khanykova OK; Kuznetsova TV; Gerasimova NA; Kozinets GI
    Antibiotiki; 1977 Jul; 22(7):639-43. PubMed ID: 883808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D; Hilliard SL
    Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
    Shorin VA; Bazhanov VS
    Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
    [No Abstract]   [Full Text] [Related]  

  • 12. An improved method for analyzing survival data from combination chemotherapy experiments.
    Carter WH; Stablein DM; Wampler GL
    Cancer Res; 1979 Sep; 39(9):3446-53. PubMed ID: 476674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiment to potentiate the effect of cyclophosphamide combined with tempidon and caffeine in leukemia L1210 and Lewis hepatic carcinoma].
    Stoichkov I; Milushev A; Todorov D
    Eksp Med Morfol; 1978; 17(1):9-14. PubMed ID: 639751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the antitumor activity of carminomycin in malignant tumors in children (a preliminary report)].
    Durnov LA; Susuleva NA; Lichinitser MR
    Antibiotiki; 1976 Jul; 21(7):654-7. PubMed ID: 782352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).
    Johnson RK; Ovejera AA; Goldin A
    Cancer Treat Rep; 1976 Jan; 60(1):99-102. PubMed ID: 826316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carminomycin in drug combination in breast cancer and soft tissue sarcomas].
    Lichinitser MR; Assekritova IV; Gorbunova VA
    Antibiotiki; 1977 Oct; 22(10):940-3. PubMed ID: 411416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic use of carminomycin in soft tissue sarcomas].
    Perevodchikova NI; Gorbunova VA; Lichinitser MR; Moroz LV
    Antibiotiki; 1976 Jul; 21(7):657-60. PubMed ID: 782353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.